文献速递妇科生殖医学

单侧卵巢切除术后激素与卵泡重排能否解释适时绝经?

Could hormonal and follicular rearrangements explain timely menopause in unilaterally oophorectomized women?
PubMed 文献 · Hum Reprod · 2021-01-01

结果显示单侧切除后剩余卵巢的每卵巢和每卵泡AMH产量及窦卵泡分布与对照相当,提示存在卵泡保护机制。

要点

  • 单侧卵巢切除后每卵巢AMH和窦卵泡计数与对照相当。
  • 每卵泡AMH产量在两组间无显著差异。
  • 剩余卵巢可能存在卵泡保护机制以维持适时绝经。

核心结论

  • 单侧卵巢切除女性校正后每卵巢和每卵泡AMH产量及窦卵泡分布与匹配对照无显著差异。

主要发现

  • 校正前单侧切除组AMH(1.46 ± 0.2 vs 2.77 ± 0.1 ng/ml,P < 0.001)和总AFC(7.3 ± 0.6 vs 15.1 ± 0.4个卵泡,P < 0.0001)低于对照组。
  • 校正后每卵巢AMH(1.46 ± 0.2 vs 1.39 ± 0.1 ng/ml)和总AFC(7.3 ± 0.6 vs 7.5 ± 0.2个卵泡)两组相当。
  • 每卵泡AMH(3-4mm、5-12mm及总)两组无显著差异(0.39 ± 0.05 vs 0.37 ± 0.02;0.69 ± 0.12 vs 0.59 ± 0.05;0.23 ± 0.03 vs 0.19 ± 0.01 ng/ml/卵泡)。
  • 3-4mm卵泡比例两组相当(66.7% vs 58.8%)。
  • 血清AMH与总AFC相关性两组相似(单侧组r = 0.70,P < 0.0001;对照组r = 0.68,P < 0.0001)。

临床怎么用

  • 单侧卵巢切除后剩余卵巢功能可能通过卵泡保护机制维持,评估卵巢储备时应考虑每卵巢参数。

局限性

  • 回顾性分析可能引入潜在偏倚。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

STUDY QUESTION: Does unilateral oophorectomy modify the relationship between serum anti-Müllerian hormone (AMH) levels and antral follicle count (AFC)? SUMMARY ANSWER: No altered 'per-ovary' and 'per-follicle' AMH production and antral follicle distribution was evident in unilaterally oophorectomized women compared to matched controls. WHAT IS KNOWN ALREADY: The age of menopause onset is relatively unchanged in patients having undergone unilateral oophorectomy. Mechanisms that occur to preserve and maintain ovarian function in this context remain to be elucidated. STUDY DESIGN, SIZE, DURATION: Forty-one infertile women, with no polycystic ovary syndrome (PCOS) and no endometriosis, aged 19-42 years old, having undergone unilateral oophorectomy (One Ovary group; average time since surgery: 23.8 ± 2.2 months) were retrospectively age-matched (±1 year) with 205 infertile women having two intact ovaries and similar clinical features (Control group). PARTICIPANTS/MATERIALS, SETTING, METHODS: Serum AMH levels, 3-4 mm AFC, 5-12 mm AFC, and total AFC (3-12 mm) were assessed on cycle Day 3 in both groups. Hormonal and ultrasonographic measurements obtained from patients in the Control group (i.e. having two ovaries) were divided by two to be compared with measurements obtained from patients of the One Ovary group (i.e. having one single remaining ovary). To estimate per-follicle AMH production, we calculated the ratio between serum AMH levels over 3-4 mm AFC, 5-12 mm AFC, and total AFC (3-12 mm), and the strength of the correlation between serum AMH levels and total AFC. The main outcome measure was to assess Day 3 AMH/Day 3 AFC ratio and hormonal-follicular correlation. MAIN RESULTS AND THE ROLE OF CHANCE: As expected, before correction, mean serum AMH levels (1.46 ± 0.2 vs 2.77 ± 0.1 ng/ml, P < 0.001) and total AFC (7.3 ± 0.6 vs 15.1 ± 0.4 follicles, P < 0.0001) were lower in the One Ovary group compared to the Control group, respectively. Yet, after correction, per-ovary AMH levels (1.46 ± 0.2 vs 1.39 ± 0.1 ng/ml) and total AFC (7.3 ± 0.6 vs 7.5 ± 0.2 follicles) values were comparable between the two groups. Consistently, per-follicle AMH levels (3-4 mm, 5-12 mm, and total) were not significantly different between the two groups (0.39 ± 0.05 vs 0.37 ± 0.02 ng/ml/follicle; 0.69 ± 0.12 vs 0.59 ± 0.05 ng/ml/follicle, and 0.23 ± 0.03 vs 0.19 ± 0.01 ng/ml/follicle; respectively). In addition, the prevalence of 3-4 mm follicles was comparable between the two groups (66.7% for One Ovary group vs 58.8% for Control group, respectively). Finally, the correlation between serum AMH levels and total AFC was similar for patients in the One Ovary group (r = 0.70; P < 0.0001) compared to those in the Control group (r = 0.68; P < 0.0001). LIMITATIONS/REASONS FOR CAUTION: The retrospective character of the analysis might lead to potential bias. WIDER IMPLICATIONS OF THE FINDINGS: The present investigation did not provide evidence of altered 'per-ovary' and 'per-follicle' AMH production and antral follicle distribution in unilaterally oophorectomized women compared to matched controls. Further studies are warranted to support the hypothesis that follicle-sparing mechanisms are clearly at stake in remaining ovaries after unilateral oophorectomy to explain their long-lasting function and timely menopausal onset. STUDY FUNDING/COMPETING INTEREST(S): The authors have no funding or competing interests to declare. TRIAL REGISTRATION NUMBER: N/A.

来源:Hum Reprod,查看原文。版权归原作者所有。

引用

  1. Grynberg M, Labrosse J, Bennani Smires B, et al. Could hormonal and follicular rearrangements explain timely menopause in unilaterally oophorectomized women? Hum Reprod. 2021. PMID: 34037751. doi:10.1093/humrep/deab132

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。